VectraCor is a leading brand that specializes in developing and commercializing a range of products designed to simplify and expedite the diagnosis, prevention, and treatment of cardiac, pulmonary, and neurological diseases. With a portfolio of patented intellectual properties, VectraCor aims to provide healthcare professionals with faster and more efficient methods for managing these conditions. One of VectraCor's flagship products is the VectraplexECG, a universal SmartECG system that offers advanced diagnostic capabilities.

Additionally, they offer the Orbit Spirometer, VB Filter for Orbit, and the Q200/HE Holter, among other cutting-edge devices and consumable products. The brand also provides innovative software solutions such as VectraplexECG Office and Medic, which streamline data management and analysis for healthcare providers. VectraCor prides itself on delivering exceptional customer care, offering support, training, and emr connectivity options to their valued clients.

Led by a team of experienced executives, including President & CEO Brad S. Schreck and Chief Medical Officer David M. Schreck, VectraCor is dedicated to building and sustaining competitive advantages in the medical field.

They work closely with a reputable Medical Advisory Board, which includes esteemed professionals like Duke University Professor Mitchell W. Krucoff and Baylor College of Medicine Professor W. Frank Peacock.

Based in Totowa, New Jersey, VectraCor is committed to revolutionizing healthcare through innovative solutions that improve patient outcomes and enhance medical professionals' efficiency. Stay connected with VectraCor by joining their newsletter or reaching out to them through their website or contact information provided